Xilio Therapeutics, Inc. (XLO) has a market capitalization of $49.67M and trades at $8.59. The 52-week range is 6.468-16.52.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-4.19, annual revenue of $43.77M.
The stock has a beta of -0.12, operates in the Healthcare sector.
